Loading clinical trials...
Loading clinical trials...
Comparison of Treatment Adherence and Toxicities of HIV Positive Patients Versus HIV Negative Cervical Cancer Patients in India
The investigators propose to prospectively study the difference in treatment (CTRT) completion and toxicities between HIV positive and HIV negative women in India with locally advanced cervical cancer receiving CTRT.
This study will compare chemoradiation completion rates for cervical cancer in two groups, women with HIV and women without HIV. The investigators will also be analyzing tumor tissue for tumor infiltrating lymphocytes which are thought to be involved in disease progression.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Tata Memorial Hospital
Mumbai, Maharashtra, India
Start Date
February 9, 2021
Primary Completion Date
May 1, 2026
Completion Date
May 1, 2026
Last Updated
September 11, 2025
180
ACTUAL participants
Radiation Therapy
RADIATION
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
NCT01875588
NCT06349642
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05639972